Loading
Latest filing published 20 Jun 2019 for Appili Therapeutics Inc..
No signal scores available.
Kevin Sullivan is a declared insider of Appili Therapeutics Inc., with filings sourced from SEDI. Activity is concentrated on a single trading day, 13 June 2019, with 2 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 20 June 2019: a transaction, in Appili Therapeutics Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations